National Swedish Study Finds COVID-19 Vaccines Not Effective After Six Months

Heavily funded by taxpayers, how durable are the COVID-19 vaccines? With unprecedented legal mandates in countries like America, investigators from Sweden’s Umeå University sought out to determine the actual durability of leading COVID-19 vaccine products. While initial efficacy appears high--helping to defend people from severe COVID-19--mounting breakthrough infections and waning immunity are known to have triggered ongoing booster programs. How durable are these young products? With limited evidence and a lack of specificity by vaccine product, a trio of researchers from the northern region of Sweden capitalized on Swedish national population data to determine if the vaccine's effectiveness lasted even six months. Overall, this study determines any benefit beyond six months isn’t certain—and appears to dissipate. And what could be considered a bombshell of a story, is that the Umeå -based authors determine that the Pfizer-BioNTech vaccine known as BNT162b2 or “Comirnaty,” the only vaccine formally approved in the United States, shows notable waning efficacy, particularly among men, the elderly, and people with comorbidities. By month six, the data indicates littl...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee